Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development.


Journal

Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427

Informations de publication

Date de publication:
19 12 2023
Historique:
received: 28 09 2022
revised: 18 07 2023
accepted: 03 08 2023
medline: 21 12 2023
pubmed: 7 9 2023
entrez: 7 9 2023
Statut: ppublish

Résumé

Atrial fibrillation (AF) is associated with tachycardia-induced cellular electrophysiology alterations which promote AF chronification and treatment resistance. Development of novel antiarrhythmic therapies is hampered by the absence of scalable experimental human models that reflect AF-associated electrical remodelling. Therefore, we aimed to assess if AF-associated remodelling of cellular electrophysiology can be simulated in human atrial-like cardiomyocytes derived from induced pluripotent stem cells in the presence of retinoic acid (iPSC-aCM), and atrial-engineered human myocardium (aEHM) under short term (24 h) and chronic (7 days) tachypacing (TP). First, 24-h electrical pacing at 3 Hz was used to investigate whether AF-associated remodelling in iPSC-aCM and aEHM would ensue. Compared to controls (24 h, 1 Hz pacing) TP-stimulated iPSC-aCM presented classical hallmarks of AF-associated remodelling: (i) decreased L-type Ca2+ current (ICa,L) and (ii) impaired activation of acetylcholine-activated inward-rectifier K+ current (IK,ACh). This resulted in action potential shortening and an absent response to the M-receptor agonist carbachol in both iPSC-aCM and aEHM subjected to TP. Accordingly, mRNA expression of the channel-subunit Kir3.4 was reduced. Selective IK,ACh blockade with tertiapin reduced basal inward-rectifier K+ current only in iPSC-aCM subjected to TP, thereby unmasking an agonist-independent constitutively active IK,ACh. To allow for long-term TP, we developed iPSC-aCM and aEHM expressing the light-gated ion-channel f-Chrimson. The same hallmarks of AF-associated remodelling were observed after optical-TP. In addition, continuous TP (7 days) led to (i) increased amplitude of inward-rectifier K+ current (IK1), (ii) hyperpolarization of the resting membrane potential, (iii) increased action potential-amplitude and upstroke velocity as well as (iv) reversibly impaired contractile function in aEHM. Classical hallmarks of AF-associated remodelling were mimicked through TP of iPSC-aCM and aEHM. The use of the ultrafast f-Chrimson depolarizing ion channel allowed us to model the time-dependence of AF-associated remodelling in vitro for the first time. The observation of electrical remodelling with associated reversible contractile dysfunction offers a novel platform for human-centric discovery of antiarrhythmic therapies.

Identifiants

pubmed: 37677054
pii: 7263227
doi: 10.1093/cvr/cvad143
pmc: PMC10730244
doi:

Substances chimiques

Anti-Arrhythmia Agents 0
Acetylcholine N9YNS0M02X

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2623-2637

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : DFG, VO 1568/3-1, VO 1568/4-1, IRTG1816 project 12, SFB1002
Organisme : German Center for Cardiovascular Research
ID : 81X2300189 and 81X4300102
Organisme : BMBF
ID : 01GM1902D
Organisme : Göttingen Promotionskolleg für Medizinstudierende
Organisme : Jacob-Henle-Programm
Organisme : Else-Kröner-Fresenius-Stiftung
Organisme : DZHK
Organisme : Fondation Leducq
ID : 20CVD04

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.

Déclaration de conflit d'intérêts

Conflict of interest: W.H.Z. is founder and advisor of Repairon GmbH and myriamed GmbH. M.T. is advisor of Repairon GmbH and myriamed GmbH. myriamed GmbH commercializes iPSC-based cell and tissue models for drug discovery. M.Rap. is an employee of Nanion Technologies GmbH. This manuscript was handled by Consulting Editor David Eisner.

Références

Circulation. 2015 Jul 14;132(2):82-92
pubmed: 25951834
Eur Heart J. 2023 Jul 14;44(27):2483-2494
pubmed: 36810794
Circulation. 2005 Dec 13;112(24):3697-706
pubmed: 16330682
Circulation. 2004 Oct 19;110(16):2299-306
pubmed: 15477405
Circulation. 2014 Jan 14;129(2):145-156
pubmed: 24249718
Nat Commun. 2018 May 1;9(1):1750
pubmed: 29717130
Eur Heart J. 2017 Jun 07;38(22):1764-1774
pubmed: 28057773
Am J Physiol Heart Circ Physiol. 2013 Jul 1;305(1):H66-75
pubmed: 23645460
Card Electrophysiol Clin. 2016 Jun;8(2):411-21
pubmed: 27261831
Nat Commun. 2020 Jan 7;11(1):75
pubmed: 31911598
J Physiol. 2007 Jul 15;582(Pt 2):675-93
pubmed: 17478540
J Mol Cell Cardiol. 2013 Aug;61:142-52
pubmed: 23531443
Circ Res. 2014 Apr 25;114(9):1483-99
pubmed: 24763466
Circ Res. 2008 Oct 10;103(8):845-54
pubmed: 18723446
J Cardiovasc Pharmacol. 2013 May;61(5):408-15
pubmed: 23364608
Circ Res. 1997 Oct;81(4):512-25
pubmed: 9314832
Cell Res. 2011 Apr;21(4):579-87
pubmed: 21102549
Int J Cardiol. 2018 Mar 15;255:61-68
pubmed: 29290419
Circ Res. 2011 Oct 28;109(10):1105-14
pubmed: 21921264
Circ Arrhythm Electrophysiol. 2010 Oct;3(5):472-80
pubmed: 20657029
Circ Res. 2020 Jun 19;127(1):51-72
pubmed: 32717172
Clin Res Cardiol. 2019 Jun;108(6):577-599
pubmed: 30306295
Circ Res. 2009 Oct 23;105(9):876-85
pubmed: 19762679
Basic Res Cardiol. 2020 Nov 30;115(6):72
pubmed: 33258071
Cardiovasc Res. 2007 Jun 1;74(3):426-37
pubmed: 17362895
JCI Insight. 2018 Jun 21;3(12):
pubmed: 29925689
Stem Cell Res. 2020 Oct;48:101944
pubmed: 33038615
Europace. 2013 May;15(5):754-60
pubmed: 23419660
Circulation. 2012 May 1;125(17):2059-70
pubmed: 22456474
J Vis Exp. 2020 Dec 22;(166):
pubmed: 33427238
Heart Rhythm. 2005 Mar;2(3):223-30
pubmed: 15851308
Circulation. 1998 Dec 1;98(22):2422-8
pubmed: 9832487
Eur Heart J. 2013 Apr;34(15):1134-46
pubmed: 23103664
Circ Res. 2007 Feb 16;100(3):425-33
pubmed: 17234964
Acta Physiol Scand. 1993 Oct;149(2):133-42
pubmed: 8266802
J Physiol. 2004 Jun 1;557(Pt 2):583-97
pubmed: 15020696
Cell. 2019 Feb 7;176(4):913-927.e18
pubmed: 30686581
J Clin Invest. 2014 Nov;124(11):4759-72
pubmed: 25329692
J Pharmacol Exp Ther. 2013 Oct;347(1):69-79
pubmed: 23887096
Curr Opin Pharmacol. 2014 Apr;15:16-21
pubmed: 24721649
EMBO Mol Med. 2015 Feb 19;7(4):394-410
pubmed: 25700171
Stem Cell Rev Rep. 2011 Nov;7(4):976-86
pubmed: 21614516
Cardiovasc Res. 2008 Jan;77(1):35-43
pubmed: 18006448
Front Cell Dev Biol. 2020 Jul 28;8:536
pubmed: 32850774
Cardiovasc Res. 2020 Jul 1;116(8):1487-1499
pubmed: 31598634
Front Physiol. 2018 Oct 08;9:1227
pubmed: 30349482
Circulation. 2017 May 9;135(19):1832-1847
pubmed: 28167635
Br J Pharmacol. 2008 Aug;154(8):1619-30
pubmed: 18536759
Cardiovasc Res. 2021 Jun 16;117(7):1718-1731
pubmed: 33982075
Europace. 2010 Feb;12(2):160-72
pubmed: 19875395
Sci Rep. 2017 Jul 13;7(1):5268
pubmed: 28706272
Circ Res. 1999 Sep 3;85(5):428-36
pubmed: 10473672
Cardiovasc Drugs Ther. 2017 Jun;31(3):325-344
pubmed: 28721524
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Life Sci. 2014 Mar 3;97(2):107-15
pubmed: 24345461
Circ Res. 2011 Oct 14;109(9):1031-43
pubmed: 21903936
Stem Cell Reports. 2015 Oct 13;5(4):647-59
pubmed: 26411904
Cardiovasc Res. 2021 Jun 16;117(7):1790-1801
pubmed: 32520995
Biomaterials. 2013 Mar;34(10):2399-411
pubmed: 23261219
J Physiol. 2016 Feb 1;594(3):537-53
pubmed: 26582329
Stem Cell Reports. 2018 Dec 11;11(6):1378-1390
pubmed: 30416051
J Clin Invest. 2013 May;123(5):1939-51
pubmed: 23543060
Cardiovasc Res. 2022 Jun 22;118(7):1613-1614
pubmed: 35425974
Cardiovasc Res. 2020 May 1;116(6):1147-1160
pubmed: 31504264
Dis Model Mech. 2019 Jul 9;12(7):
pubmed: 31208990
STAR Protoc. 2020 Jun 03;1(1):100032
pubmed: 33111083
Circ Res. 2020 Jun 19;127(1):21-33
pubmed: 32716721
J Am Coll Cardiol. 2003 Mar 5;41(5):858-69
pubmed: 12628735
Commun Biol. 2022 Sep 15;5(1):969
pubmed: 36109584
Cardiovasc Res. 2005 Jul 1;67(1):69-76
pubmed: 15949471
Cell Stem Cell. 2017 Aug 3;21(2):179-194.e4
pubmed: 28777944
Development. 2017 Mar 15;144(6):1008-1017
pubmed: 28279973
Circulation. 2004 Oct 26;110(17):2651-7
pubmed: 15492323
Circ Res. 2020 Jun 19;127(1):91-110
pubmed: 32716814
Cardiovasc Res. 1999 May;42(2):434-42
pubmed: 10533579
Elife. 2017 Jan 30;6:
pubmed: 28134617
STAR Protoc. 2020 Jun 03;1(1):100026
pubmed: 33111079
Circulation. 2020 Sep 29;142(13):1261-1278
pubmed: 32686471
Basic Res Cardiol. 2022 May 2;117(1):5
pubmed: 35499658
Water Res. 2018 Jan 1;128:314-330
pubmed: 29107916
J Cardiovasc Pharmacol. 2020 Dec 13;77(3):291-299
pubmed: 33278190
Sci Rep. 2015 Oct 21;5:15187
pubmed: 26487066
Circulation. 1995 Oct 1;92(7):1954-68
pubmed: 7671380

Auteurs

Fitzwilliam Seibertz (F)

Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
Cluster of Excellence 'Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells' (MBExC), University of Göttingen, Göttingen, Germany.

Tony Rubio (T)

Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.

Robin Springer (R)

Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.

Fiona Popp (F)

Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.

Melanie Ritter (M)

Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.

Aiste Liutkute (A)

Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.

Lena Bartelt (L)

Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.

Lea Stelzer (L)

Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.

Fereshteh Haghighi (F)

DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
Department of Cardiothoracic and Vascular Surgery, Georg-August-University Göttingen, Göttingen, Germany.

Jan Pietras (J)

DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
Department of Cardiothoracic and Vascular Surgery, Georg-August-University Göttingen, Göttingen, Germany.

Hendrik Windel (H)

DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
Department of Cardiothoracic and Vascular Surgery, Georg-August-University Göttingen, Göttingen, Germany.

Núria Díaz I Pedrosa (NDI)

Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.

Markus Rapedius (M)

Nanion Technologies GmbH, Munich, Germany.

Yannic Doering (Y)

Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.

Richard Solano (R)

Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
Department of Cardiothoracic and Vascular Surgery, Georg-August-University Göttingen, Göttingen, Germany.

Robin Hindmarsh (R)

DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
Clinic for Cardiology and Pneumology, University Medical Center Göttingen, Georg-August University Göttingen, Germany.

Runzhu Shi (R)

DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
Institute for Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany.

Malte Tiburcy (M)

Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.

Tobias Bruegmann (T)

DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
Cluster of Excellence 'Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells' (MBExC), University of Göttingen, Göttingen, Germany.
Institute for Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany.

Ingo Kutschka (I)

DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
Department of Cardiothoracic and Vascular Surgery, Georg-August-University Göttingen, Göttingen, Germany.

Katrin Streckfuss-Bömeke (K)

DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
Clinic for Cardiology and Pneumology, University Medical Center Göttingen, Georg-August University Göttingen, Germany.
Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.

George Kensah (G)

DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
Department of Cardiothoracic and Vascular Surgery, Georg-August-University Göttingen, Göttingen, Germany.

Lukas Cyganek (L)

DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
Cluster of Excellence 'Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells' (MBExC), University of Göttingen, Göttingen, Germany.
Clinic for Cardiology and Pneumology, University Medical Center Göttingen, Georg-August University Göttingen, Germany.

Wolfram H Zimmermann (WH)

Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
Cluster of Excellence 'Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells' (MBExC), University of Göttingen, Göttingen, Germany.
German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Göttingen, Germany.
Campus-Institute Data Science (CIDAS), University of Göttingen, Göttingen, Germany.

Niels Voigt (N)

Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
Cluster of Excellence 'Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells' (MBExC), University of Göttingen, Göttingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH